ASH 2018 | CAR T-cell therapy: a new outlook for older patients with aggressive lymphomas?

Raúl Córdoba

Raúl Córdoba, MD, PhD, MS, of the Fundación Jiménez Diaz University Hospital, Madrid, Spain, speaks at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA., on the utilization of CAR T-cell therapy as a new approach for elderly patients with lymphomas, including those with aggressive forms of the disease.

Share this video